Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study.
about
Role of therapeutic fasting in women's health: An overviewChronic Inflammatory Diseases and Endothelial DysfunctionHyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.Metabolic syndrome in the elderly: an overview of the evidence.PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.Estimation of the Long-term Cardiovascular Events Using UKPDS Risk Engine in Metabolic Syndrome Patients.Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis.Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation.Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation.Prevalence of metabolic syndrome in Iranian professional drivers: results from a population based study of 12,138 men.Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters.Antiobesity and hypolipidemic effects of lotus leaf hot water extract with taurine supplementation in rats fed a high fat diet.Impact of metabolic syndrome on the prognosis of ischemic stroke secondary to symptomatic intracranial atherosclerosis in Chinese patients.Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjectsSonographic fatty liver, overweight and ischemic heart disease.Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly.Epidemiology and treatment of the metabolic syndrome.Effects of health intervention program on cardiometabolic risk profiles from health evaluation center in Asian population: a longitudinal study and propensity analysis.Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey.Atherosclerotic cardiovascular disease risk in the HAART-treated HIV-1 population.Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics.Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women.Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study.Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats.Gender differences in association between metabolic syndrome and carotid intima media thickness.Impact of gender and menopausal status on metabolic parameters in chronic hepatitis C infection.Prevalence and component analysis of metabolic syndrome: an Indian atherosclerosis research study perspective.The role of endocannabinoid system blockade in the treatment of the metabolic syndrome.The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trialMetabolic syndrome: an evolving threat in the genesis of coronary artery disease.Ten-year cardiovascular risk in the general public of Hong Kong.Occupation and metabolic syndrome: is there correlation? A cross sectional study in different work activity occupations of German firefighters and office workers.Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.The Cooperative Lifestyle Intervention Program-II (CLIP-II): design and methods.Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study.Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome
P2860
Q26738683-31DB8E7F-689D-4F69-9AAD-7026EA7A443DQ26774158-69B45208-6050-47B8-8748-2B3ACEDA94E6Q33380194-C7322FD9-6C68-49BA-98F7-8088BEB7A5D1Q33421460-7D8280E2-E5CC-4A8D-9742-D54765D3FB3EQ33572702-BF5BA0B2-0813-488E-BDEC-3388A9A73728Q33621120-22339190-C316-4288-A1E3-711FDBA27CF9Q33641584-2069495B-8AD9-4B02-9C18-5FB2334DCA57Q33950646-96253E22-8013-4517-BEC0-2A9F7493E9A4Q34175422-C7165FA8-CD05-4674-BD6D-53580F2A783BQ34181960-77A3C5F5-2DE0-4593-91FA-9C1E79271CC3Q34283290-36E46BB7-984C-4C39-BE02-875FE2838BF4Q34364463-C20369B0-7454-4234-9F8F-E5F11F0DC0C0Q34516611-B07B0835-C453-4698-970A-2CC2BFA46996Q34722566-CFC6884E-4918-4923-B9E0-3209B8C78C84Q35435689-B99088AD-D735-4218-B498-218B356BEE7BQ35492436-A1D24BBC-49EB-4AB6-8FED-7E3AF8117139Q35556049-545A49CC-1CA9-4610-9982-EDE4B9D8F10AQ35915241-B1DC678D-C9A0-43C5-A6F6-7B133F4242FDQ35986083-2DBB3A7D-9C80-458F-9600-3B19208960D5Q36049231-A110FF22-2908-47FC-99D2-EC190862084AQ36070094-CFB5244F-72C3-4261-A695-E40E81E954F1Q36081993-D9FE3440-EC04-48A1-BCB9-7A856757D4EBQ36175864-C05107B9-F459-49B4-B651-F0E8A51F56DAQ36266034-C5DA917E-994D-495C-AC7D-8D8C3E935F9DQ36517372-DE535AAF-CA6E-4466-B109-0170575F5C71Q36671813-DC7B0009-572F-4DBE-9AA8-9A43DA6110A9Q36686301-61A45681-3411-4C04-B109-EF8818C218CAQ36734252-59A97F57-6ADA-412D-922A-7167C2177120Q36766920-4E4017D2-02CE-4AB2-93D1-534A765DEE78Q36773310-2997115B-82AA-4C8A-A8E6-BC549BF86FE8Q36825706-3D1DD9F7-86B6-485E-AF8A-7BCFBF632FEAQ36929371-F9546B05-D3F1-4358-B3B4-FD7FB9614267Q36982627-E2205AC0-6CB8-4C2E-9271-8691A9D4CA1BQ37196419-1AAA884F-58B6-41CD-B67A-CED9D44B6208Q37205022-55AC8F78-1A96-48C1-B2D2-688E29B5B35EQ37350467-DE1B6851-B67F-4A98-B907-CB1B640F4B1DQ37350949-8D273BA5-ACF0-496E-979D-5DA26F17D59FQ37384100-A64B684F-4156-48F3-8A24-1E7E88D4EC87Q37417693-F2ECEE70-F612-47B2-A9A3-A2F5C32DE7A5Q37643052-C579E688-CF46-43A3-8131-48BB52509C88
P2860
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Carotid atherosclerosis and co ...... e data from the Bruneck study.
@ast
Carotid atherosclerosis and co ...... e data from the Bruneck study.
@en
type
label
Carotid atherosclerosis and co ...... e data from the Bruneck study.
@ast
Carotid atherosclerosis and co ...... e data from the Bruneck study.
@en
prefLabel
Carotid atherosclerosis and co ...... e data from the Bruneck study.
@ast
Carotid atherosclerosis and co ...... e data from the Bruneck study.
@en
P2093
P1433
P1476
Carotid atherosclerosis and co ...... e data from the Bruneck study.
@en
P2093
Bruneck study
Enzo Bonora
Friedrich Oberhollenzer
Georg Egger
Johann Willeit
Michele Muggeo
Stefan Kiechl
P304
P356
10.2337/DIACARE.26.4.1251
P407
P577
2003-04-01T00:00:00Z